Gerhild Fabjani - Search Results

Year	Number of Results
2002	3
2003	2
2005	3
2007	2
2008	1
2011	1
2015	1
2016	1
2024	0

1

Genetic alterations in endometrial hyperplasia and cancer.

Fabjani G, Kucera E, Schuster E, Minai-Pour M, Czerwenka K, Sliutz G, Leodolter S, Reiner A, Zeillinger R. Fabjani G, et al. Cancer Lett. 2002 Jan 25;175(2):205-11. doi: 10.1016/s0304-3835(01)00714-5. Cancer Lett. 2002. PMID: 11741749

2

Biochip for K-ras mutation screening in ovarian cancer.

Fabjani G, Kriegshaeuser G, Schuetz A, Prix L, Zeillinger R. Fabjani G, et al. Clin Chem. 2005 Apr;51(4):784-7. doi: 10.1373/clinchem.2004.041194. Clin Chem. 2005. PMID: 15788786 No abstract available.

3

Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells.

Brozek W, Bises G, Fabjani G, Cross HS, Peterlik M. Brozek W, et al. Among authors: fabjani g. BMC Cancer. 2008 Jan 18;8:13. doi: 10.1186/1471-2407-8-13. BMC Cancer. 2008. PMID: 18205904 Free PMC article.

4

Tumor necrosis factor-alpha promotor polymorphisms and endometriosis.

Wieser F, Fabjani G, Tempfer C, Schneeberger C, Zeillinger R, Huber JC, Wenzl R. Wieser F, et al. Among authors: fabjani g. J Soc Gynecol Investig. 2002 Sep-Oct;9(5):313-8. doi: 10.1016/s1071-5576(02)00174-0. J Soc Gynecol Investig. 2002. PMID: 12383917

5

The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells.

Schmid BC, Rezniczek GA, Fabjani G, Yoneda T, Leodolter S, Zeillinger R. Schmid BC, et al. Among authors: fabjani g. Breast Cancer Res Treat. 2007 Dec;106(3):333-42. doi: 10.1007/s10549-007-9504-0. Epub 2007 Feb 1. Breast Cancer Res Treat. 2007. PMID: 17268810

6

Biochip-based detection of KRAS mutation in non-small cell lung cancer.

Kriegshäuser G, Fabjani G, Ziegler B, Zöchbauer-Müller S, End A, Zeillinger R. Kriegshäuser G, et al. Among authors: fabjani g. Int J Mol Sci. 2011;12(12):8530-8. doi: 10.3390/ijms12128530. Epub 2011 Nov 29. Int J Mol Sci. 2011. PMID: 22272089 Free PMC article.

7

Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.

Schmid BC, Rudas M, Fabjani G, Speiser P, Kaserer K, Leodolter S, Zeillinger R. Schmid BC, et al. Among authors: fabjani g. Oncol Rep. 2003 Nov-Dec;10(6):1981-5. Oncol Rep. 2003. PMID: 14534730

8

The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.

Watrowski R, Castillo-Tong DC, Fabjani G, Schuster E, Fischer M, Zeillinger R. Watrowski R, et al. Among authors: fabjani g. Tumour Biol. 2016 Jan;37(1):1009-15. doi: 10.1007/s13277-015-3847-7. Epub 2015 Aug 12. Tumour Biol. 2016. PMID: 26264612

9

Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.

Mustea A, Sehouli J, Fabjani G, Koensgen D, Möbus V, Braicu EI, Pirvulescu C, Thomas A, Tong D, Zeillinger R. Mustea A, et al. Among authors: fabjani g. Anticancer Res. 2007 May-Jun;27(3B):1527-30. Anticancer Res. 2007. PMID: 17595771 Free article.

10

HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.

Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, Fischer MB, Jakesz R, Zeillinger R. Fabjani G, et al. Oncol Rep. 2005 Sep;14(3):737-41. Oncol Rep. 2005. PMID: 16077985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year